Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • chadn737
    Senior Member
    • Jan 2009
    • 392

    #1

    Multiplexing experimental design question.

    We are doing an RNA-seq experiment comparing a wild type sample to a mutant. There are three biological reps of each, each tagged with a unique barcode.

    These will be run on two lanes of an Illumina Hi-Seq. Our core averages around 65 million reads per lane.

    I'm thinking that the ideal setup here is to multiplex all 6 samples on both lanes and combine the reads for each sample afterwards. In theory, this should eliminate any lane-lane variation between the samples as this will be spread across all 6 samples.

    Or am I wrong in this? Is it better to multiplex 3 of all our wild type in one lane and 3 of our mutant in another. Or maybe a design of 2 WT 1 mutant in one lane and 2 mutant 1 WT in the other. I would think in either case we should average ~20 million reads per sample, but that the first is the ideal setup.

    Any thoughts on this? I know many claim that the technical variation observed is minimal, but I like to eliminate as many confounding factors as possible.
    Last edited by chadn737; 04-12-2011, 02:18 PM.
  • Camg
    Member
    • Jan 2011
    • 21

    #2
    I think your first idea is right, you should barcode each sample and run them all in each lane.

    Check out this reference: http://www.genetics.org/cgi/reprint/185/2/405

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...